Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome

Journal of Gastrointestinal Surgery

Volumn 11, Issue 12, 2007, Pages 1589-1597

  Williams, Valerie A ^a,b   Watson, Thomas J ^a,b   Herbella, Fernando A ^a   Gellersen, Oliver ^a   Raymond, Daniel ^a   Jones, Carolyn ^a   Peters, Jeffrey H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Esophageal cancer; Esophagectomy; High grade dysplasia

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; ESOPHAGUS; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 36148946802     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0330-9     Document Type: Article

References (45)

1. Pohl H, Welch HG. J Natl Cancer Inst. 2005;97:142-146.
2. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society, 2007. http://www.cancer.org Last accessed March 31, 2007.
3. Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96:1249-1256.
4. Spechler SJ. The natural history of dysplasia and cancer in esophagitis and Barrett esophagus. J Clin Gastroenterol. 2003;36(5 Suppl):S2-S5. (discussion S26-S28).
5. Ormsby AH, Petras RE, Henricks WH, Rice TW, Rybicki LA, Richter JE, Goldblum JR. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut. 2002;51:671-676.
6. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32(4):368-378.
7. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus: Comparison of benign and malignant cases. Ann Surg. 1983;198:554-566.
8. Schmidt HG, Riddell RD, Walther B, et al. Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol. 1985;110:145-152.
9. Lee RG. Dysplasia in Barrett's esophagus: A clinicopathologic study of six patients. Am J Surg Pathol. 1985. 845-852.
10. Hamilton SR, Smith RL. The relationship between columnar epithelial dysplasia and invasive carcinoma arising in Barrett's esophagus. Am J Clin Pathol. 1987;87:301-312.
11. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology. 1998;94:81-90.
12. DeMeester TR, Attwood SE, Smyrk TC, Therkildsen DH, Hinder RA. Surgical therapy in Barrett's esophagus. Ann Surg. 1990;212(4):528-540.
13. Altorki NK, Sunagaawa M, Little AG, et al. High-grade dysplasia in the columnar-lined esophagus. Am J Surg. 1991;161:97-100.
14. McArdle JE, Lewin KJ, Randall G, et al. Distribution of dysplasia and early invasive carcinoma in Barrett's esophagus. Hum Pathol. 1992;23:479-482.
15. Pera M, Trastek VF, Carpenter HA, et al. Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy. Ann Thorac Surg. 1999;54:204.
16. Levine DS, Haggett RC, Blout PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology. 1993;105:40-50.
17. Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett's esophagus: does it help? J Thorac Cardiovasc Surg. 1993;105(3):383-388.
18. Ortiz A, Martinez de Haro LF, Parrilla P, et al. Conservative treatment versus antireflux surgery in Barrett's esophagus: Long-term results of a prospective study. Br J Surg. 1996;83:274-227.
19. Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg. 1994;108(5):813-822.
20. Edwards MJ, Gable DR, Lentsch AB, et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg. 1996;223:585-591.
21. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: Implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997;114:824-829.
22. Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: A pathological study. Am J Gastroenterol. 1997;92:586-591.
23. Patti MG, Arcerito M, Feo CV, Worth S, De Pinto M, Gibbs VC, Gantert VC, Tyrrell D, Ferrell LF, Way LW. Barrett's esophagus: a surgical disease. J Gastrointest Surg. 1999;3(4):397-403.
24. Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma: Extent of disease and implications for effective therapy. Ann Surg. 1990;230:433-444.
25. Nguyen NT, Schauer P, Luketich JD. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. Surgery. 2000;127:284-290.
26. Zaninotto G, Parenti AR, Ruol A, et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg. 2000;87:1102-1105.
27. Headrick JR, Nichols FC, Miller DL, Allen MS, Trastek VF, Deschamps C, Schleck CD, Thompson AM, Pairolero PC. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg. 2002;73(6):1697-1703.
28. Romagnoli R, Collard JM, Gutschow C, Yamusah N, Salizzoni M. Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view. J Am Coll Surg. 2003;197:365-371.
29. Tseng EE, Wu TT, Yeo CJ, Heitmiller RF. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome - an update. J Gastrointest Surg. 2003;7(2):164-170.
30. Reed MF, Tolis G, Edil BH, Allan JS, Donahue DM, Gaissert HA, Moncure AC, Wain JC, Wright CD, Mathisen DJ. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg. 2005;79:1110-1115.
31. Sujendran V, Sica G, Warren B, Maynard N. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. Eur J Cardiothorac Surg. 2005;28:763-766.
32. Moraca RJ, Low DE. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg. 2006;141:545-551.
33. Rice TW. Esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol. 2006;101:2177-2184.
34. Chang LC, Oelschlager BK, Quiroga E, Parra JD, Mulligan M, Wood DE, Pellegrini CA. Long-term outcome for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg. 2006;10:341-346.
35. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980;67:381-390.
36. Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg. 2003;75:217-222.
37. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Eng J Med. 2002;346(15):1128-1137.
38. Swanson SJ, Batirel HF, Bueno R, Jaklitsch MT, Lukanich JM, Allred E, Mentzer SJ, Sugarbaker DJ. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg. 2001;72:1918-1925.
39. Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236(2):177-183.
40. Portale G, Hagen JA, Peters JH, Chan LS, DeMeester SR, Gandamihardja TA, DeMeeser TR. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006;202(4):588-596.
41. Hulscher JBF, van Sandick JW, de Boer AGEM, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;3477:1662-1669.
42. Schnell TG, Sontag SL, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001;120(7):1607-1619.
43. Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004;99(9):1657-1666.
44. Oh DS, Hagen JA, Chandrasoma PT, et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg. 2006;203:152-161.
45. Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120(7):1630-1639.